All filters
E-Posters
Occult HBV infection and two clinical cases with malignant comorbidities
V. Aster
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Associations between HLA Class II- DRB1 Alleles with susceptibility to Viral Hepatitis B and C in patients with HIV infection
L. Shostakovych-Koretskaya
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Avidity of antibodies to hepatitis C virus in persons with newly diagnosed HCV infection
V. Khombak
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Prevalence of Hepatitis among the general population in Botswana from the STI microbial survey of 2017/2018
D. Kanyenvu
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Simplified ART regime on the background of multi-allergy in an elderly HIV-infected patient
N. Matsiyeuskaya
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
E-Posters
Randomized control trial of home-based hepatitis C self-testing in key populations in Georgia
M. Japaridze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveys
A. Abutidze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, Georgia
L. Sharvadze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine
Z. Islam
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Dynamics and peculiarities of AIDS mortality in Minsk, Belarus
M. Shylava
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”
O. Chokoshvili
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort study
R. Metchurtchlishvili
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030
B. Vu
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Prevalence of undiagnosed HBV infection in patients with COVID-19
V. Miron
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Obstetric complications in HIV-positive pregnant women, depending on the level of HIV RNA and CD4 count
O. Мозалева
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Post-discharge mortality among hospitalized HIV positive persons
N. Rukhadze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021
E. Karkashadze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Surveillance of SARS-CoV-2 among employees of front-line healthcare facility in Tbilisi Georgia
N. Chkhartishvili
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population
S. Grubyte
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Prevalence of hyperglycemia and its impact on mortality among HIV patients in Georgia
T. Nozadze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Assessment of HCV screening and linkage to care modalities within the Georgia’s national Hepatitis C elimination program and designing the most optimal models for reaching the elimination targets
A. Abutidze
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Molecular epidemiology of Hepatitis C virus isolated from patients with newly diagnosed HCV infection in 2017-2021
N. Matsiyeuskaya
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Surveillance of recent HIV infection in Georgia, 2018-2020
M. Karchava
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
“ALT flare” implication into further TDF-containing chronic hepatitis B therapy effectiveness among people living with HIV
T. Melnyk
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021